@article{3000394,
    title = "Isolation of candida auris from cystic fibrosis patient, Greece, april 2019",
    author = "Stathi, A. and Loukou, I. and Kirikou, H. and Petrocheilou, A. and Moustaki, M. and Velegraki, A. and Zachariadou, L.",
    journal = "Eurosurveillance",
    year = "2019",
    volume = "24",
    number = "29",
    publisher = "European Centre for Disease Prevention and Control (ECDC)",
    issn = "1025-496X, 1560-7917",
    doi = "10.2807/1560-7917.ES.2019.24.29.1900400",
    keywords = "amphotericin B;  anidulafungin;  caspofungin;  ciprofloxacin;  colistin;  fluconazole;  flucytosine;  internal transcribed spacer;  isavuconazole;  itraconazole;  ivacaftor plus lumacaftor;  micafungin;  posaconazole;  tobramycin;  antifungal agent;  antiinfective agent;  posaconazole;  triazole derivative, antifungal susceptibility;  Article;  Candida;  Candida auris;  Candida duobushaemulonii;  case report;  chronic disease;  clinical article;  clinical evaluation;  coughing;  cystic fibrosis;  disease exacerbation;  disease predisposition;  drug withdrawal;  fungus identification;  fungus isolation;  Greece;  human;  immunosuppressive treatment;  lung aspergillosis;  lung disease;  male;  matrix assisted laser desorption ionization time of flight mass spectrometry;  minimum inhibitory concentration;  mycosis;  nonhuman;  nucleotide sequence;  patient compliance;  Pseudomonas infection;  pulmonary candidiasis;  species identification;  sputum;  symptom;  treatment duration;  complication;  cystic fibrosis;  DNA sequence;  drug effect;  isolation and purification;  matrix-assisted laser desorption-ionization mass spectrometry;  microbial sensitivity test;  microbiological examination;  microbiology;  phylogeny;  procedures;  species difference;  treatment outcome;  young adult, Anti-Bacterial Agents;  Antifungal Agents;  Candida;  Cystic Fibrosis;  Greece;  Humans;  Microbial Sensitivity Tests;  Mycological Typing Techniques;  Phylogeny;  Sequence Analysis, DNA;  Species Specificity;  Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization;  Sputum;  Treatment Outcome;  Triazoles;  Young Adult",
    abstract = "We report the first isolation of Candida auris in Greece from a sputum culture of a cystic fibrosis patient in their 20s under posaconazole treatment. The pathogen was identified as C. duobushaemulonii by VITEK2YST, but as C. auris by MALDI-TOF MS. This case underscores the need for species-level identification of all non-albicans Candida (NAC) isolates from cystic fibrosis patients and patients with predisposing factors to fungal infection. © 2019, European Centre for Disease Prevention and Control (ECDC). All rights reserved."
}